Danaher Co. (NYSE:DHR) SVP Angela S. Lalor sold 3,091 shares of the firm’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $132.23, for a total transaction of $408,722.93. Following the sale, the senior vice president now owns 38,515 shares of the company’s stock, valued at $5,092,838.45. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Shares of DHR stock opened at $130.21 on Wednesday. Danaher Co. has a 52 week low of $94.59 and a 52 week high of $134.67. The company has a market capitalization of $93.86 billion, a PE ratio of 28.81, a P/E/G ratio of 2.53 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.18 and a quick ratio of 1.74.
Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, April 18th. The conglomerate reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.06. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The firm had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.80 billion. During the same period in the previous year, the business posted $0.99 earnings per share. The business’s revenue for the quarter was up 3.9% on a year-over-year basis. Equities research analysts anticipate that Danaher Co. will post 4.77 EPS for the current fiscal year.
A number of research firms have weighed in on DHR. Zacks Investment Research lowered shares of Danaher from a “hold” rating to a “sell” rating in a research note on Tuesday, April 30th. Needham & Company LLC restated a “buy” rating and set a $141.00 price objective (up from $138.00) on shares of Danaher in a research note on Wednesday, April 17th. Jefferies Financial Group raised their price objective on shares of Danaher to $140.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Deutsche Bank raised their price objective on shares of Danaher to $130.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Finally, UBS Group raised their price objective on shares of Danaher from $125.00 to $144.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Danaher presently has a consensus rating of “Buy” and an average target price of $131.75.
Several hedge funds have recently made changes to their positions in the company. Canton Hathaway LLC boosted its holdings in shares of Danaher by 8.7% in the first quarter. Canton Hathaway LLC now owns 12,886 shares of the conglomerate’s stock worth $1,701,000 after buying an additional 1,036 shares during the last quarter. Abacus Planning Group Inc. boosted its holdings in shares of Danaher by 52.3% in the fourth quarter. Abacus Planning Group Inc. now owns 9,979 shares of the conglomerate’s stock worth $225,000 after buying an additional 3,428 shares during the last quarter. Municipal Employees Retirement System of Michigan purchased a new position in shares of Danaher in the fourth quarter worth approximately $1,705,000. IHT Wealth Management LLC boosted its holdings in shares of Danaher by 5.1% in the fourth quarter. IHT Wealth Management LLC now owns 2,023 shares of the conglomerate’s stock worth $209,000 after buying an additional 98 shares during the last quarter. Finally, Findlay Park Partners LLP boosted its holdings in shares of Danaher by 0.9% in the first quarter. Findlay Park Partners LLP now owns 4,635,000 shares of the conglomerate’s stock worth $611,913,000 after buying an additional 40,000 shares during the last quarter. Hedge funds and other institutional investors own 76.98% of the company’s stock.
WARNING: “Danaher Co. (DHR) SVP Sells $408,722.93 in Stock” was first reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.baseballdailydigest.com/news/2019/05/22/danaher-co-dhr-svp-sells-408722-93-in-stock.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Further Reading: What is a recession?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.